What is the likely cause of eosinophilic gastritis in a patient with schizophrenia taking clozapine (clozapine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clozapine-Induced Eosinophilia

In a patient with schizophrenia taking clozapine, eosinophilic gastritis is most likely caused by clozapine itself, as clozapine-induced eosinophilia occurs in approximately 1% of patients and can be associated with organ-specific inflammation including colitis, hepatitis, pancreatitis, and nephritis. 1

Mechanism and Incidence

  • Clozapine causes eosinophilia (defined as blood eosinophil count >700/µL) in approximately 1% of patients in clinical trials, though some studies report incidence as high as 2.2% 1, 2
  • Women have a significantly higher risk of developing clozapine-induced eosinophilia (23%) compared to men (7%), with p<0.01 3
  • The eosinophilia typically occurs during the first month of treatment, most commonly between weeks 3-5 1, 3

Organ Involvement Pattern

  • Clozapine-related eosinophilia can be associated with organ-specific disease including myocarditis, pancreatitis, hepatitis, colitis, and nephritis 1
  • This pattern is consistent with drug reaction with eosinophilia and systemic symptoms syndrome (DRESS), also known as drug-induced hypersensitivity syndrome (DIHS) 1
  • Eosinophilic gastritis in this context represents gastrointestinal organ involvement from the systemic eosinophilic reaction to clozapine 1

Critical Management Decision Points

If eosinophilia develops with organ involvement (such as gastritis):

  • Evaluate promptly for signs and symptoms of systemic reactions including rash, allergic symptoms, myocarditis, or other organ-specific disease 1
  • If clozapine-related systemic disease is suspected, discontinue clozapine immediately 1

If eosinophilia develops without organ involvement:

  • Continue clozapine under careful monitoring, as eosinophilia can resolve spontaneously without intervention in many cases 1, 2
  • Monitor complete blood count with differential closely to track eosinophil count 2
  • The eosinophilia typically resolves within 3 weeks despite ongoing clozapine treatment, suggesting an acute allergic reaction mechanism 2

Important Caveats

  • Rule out alternative causes of eosinophilia before attributing it to clozapine, including asthma, allergies, collagen vascular disease, parasitic infections, and specific neoplasms 1
  • If an unrelated cause is identified, treat the underlying condition and continue clozapine 1
  • Successful rechallenge after discontinuation has been reported in cases where clozapine was stopped due to eosinophilia without organ inflammation 4
  • The pathophysiology remains unknown, but spontaneous resolution despite continued treatment suggests a transient hypersensitivity mechanism 2

Monitoring Protocol

  • Obtain baseline complete blood count before initiating clozapine 1
  • If eosinophilia develops with gastritis or other organ involvement, immediate discontinuation is mandatory 1
  • If eosinophilia continues to increase over several weeks without systemic disease, the decision to interrupt therapy should be made in consultation with an internist or hematologist 1

References

Research

Continuation with clozapine after eosinophilia: a case report.

Annals of general psychiatry, 2017

Research

High risk of eosinophilia in women treated with clozapine.

The Journal of clinical psychiatry, 1993

Research

Successful rechallenge with clozapine after treatment associated eosinophilia.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.